Amgen deal expands manufacturing capabilities in Turkey; FDA offers help to small operators;

> Amgen ($AMGN) has completed the acquisition of Turkey-based Mustafa Nevzat Pharmaceuticals, which will expand its reach in an area of fast growth. Story

> Biogen Idec ($BIIB) expects the market for injectable MS drugs to shrink as patients choose more convenient delivery forms. Article

> The FDA is offering draft guidance for small companies on how to comply with rules for labeling pharmaceuticals with toll-free numbers for reporting adverse affects. Release

> Nigeria's second-largest drugmaker, May & Baker of Nigeria, reports that it is about to start vaccine production as part of a joint venture with the government. Story

And Finally... Having integrated the acquisition of Pharmacontrol Electronic, Mettler Toledo is taking what it calls its ramped-up track-and-trace product to the U.S. Story

Suggested Articles

Pfizer is ponying up $500 million on top of $100 million already committed to a gene therapy manufacturing facility in North Carolina.

Hikma says it has picked up some pipeline products and nasal and sublingual spray equipment from Insys Therapeutics' bankruptcy.

WuXi Biologics expects to have a plant in Europe complete in 2021 as a capacity race plays out among Asia’s rapidly growing biologics CDMOs.